Status:
TERMINATED
Endothelial Dysfunction Among Woman With Endometriosis
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Endometriosis
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Endometriosis is a chronic disease defined as an ectopic endometrial tissue outside the, and associated with chronic inflammatory state and increased risk of atherosclerosis. Endothelial dysfunction ...
Detailed Description
Endometriosis is a chronic disease defined as an ectopic endometrial tissue outside the uterus, mostly in the pelvis. It is related to major morbidity and infertility. It is also associated with chron...
Eligibility Criteria
Inclusion
- Women who undergoing surgery for removal of endometriosis implants
Exclusion
- Women under 18 or above 60 years of age
- Women with known vascular disease
- Women with chronic disease which effect the endothelial function (Diabetes mellitus, Hypertension, Obesity (Defined as BMI≥30), Atherosclerosis, Kidney disease, Collagen disease, Chronic inflammatory disease, and Etc.
- History of Cardio-vascular event or venous thromboembolism (VTE)
- Smoking
- Pregnant women or gave birth in the past 3 months
Key Trial Info
Start Date :
August 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 13 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04013126
Start Date
August 12 2019
End Date
September 13 2023
Last Update
September 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haemek Medical Center
Afula, Israel